deltatrials
Completed PHASE4 NCT00169611

NF1-Attention: Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate

Comportemental and Neuropsychologic Study of Children With Neurofibromatosis Type 1 Treated by Methylphenidate. A Double-blind Randomised Study Methylphenidate Versus Placebo

Sponsor: Hospices Civils de Lyon

Conditions Neurofibromatosis Type 1
Interventions methylphenidate
Updated 5 times since 2017 Last updated: Jan 26, 2011 Started: Jan 31, 2004 Primary completion: Jan 31, 2011 Completion: Jan 31, 2011

This PHASE4 trial investigates Neurofibromatosis Type 1 and is currently completed. Hospices Civils de Lyon leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Jan 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hospices Civils de Lyon
Data source: Hospices Civils de Lyon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Lyon, France